<b>バイオバンクにおける同意撤回の自由と不帰投点 (Point of No Return)</b> <b>Inalienable Right to Withdraw from Study and the Point of No Return in the Context of Biobank Research</b>

この論文にアクセスする

著者

    • 松井 健志 MATSUI Kenji
    • 独立行政法人国立循環器病研究センター医学倫理研究室|独立行政法人国立循環器病研究センターバイオバンク個人情報管理室 Office for Research Ethics & Bioethics, National Cerebral and Cardiovascular Center|Office of Personal Information Protection, National Cerebral and Cardiovascular Center Biobank
    • 會澤 久仁子 AIZAWA Kuniko
    • 独立行政法人国立循環器病研究センター医学倫理研究室 Office for Research Ethics & Bioethics, National Cerebral and Cardiovascular Center
    • 玉腰 暁子 TAMAKOSHI Akiko
    • 北海道大学医学研究科予防医学講座公衆衛生学分野 Department of Public Health, Hokkaido University Graduate School of Medicine

抄録

Research participants are generally granted the freedom to withdraw from participating in a medical research at any time without providing any reason. However, this generally accepted practice of allowing participants the inalienable right to withdraw is not necessarily an ethical requirement. Ethics provides room to restrict a participants' freedom to withdrawal under certain conditions. Taking into consideration the current state of consent withdrawal in actual biobanking research and the possibility of eliminating any reliance on researchers' discretion, it is more appropriate both ethically and practically to limit the duration to 6 months in which participants are guaranteed the inalienable right to withdraw from a study.

Research participants are generally granted the freedom to withdraw from participating in a medical research at any time without providing any reason. However, this generally accepted practice of allowing participants the inalienable right to withdraw is not necessarily an ethical requirement. Ethics provides room to restrict a participants' freedom to withdrawal under certain conditions. Taking into consideration the current state of consent withdrawal in actual biobanking research and the possibility of eliminating any reliance on researchers' discretion, it is more appropriate both ethically and practically to limit the duration to 6 months in which participants are guaranteed the inalienable right to withdraw from a study.

収録刊行物

  • 臨床薬理

    臨床薬理 45(1), 17-23, 2014

    一般社団法人 日本臨床薬理学会

各種コード

  • NII論文ID(NAID)
    130004541576
  • 本文言語コード
    JPN
  • ISSN
    0388-1601
  • データ提供元
    J-STAGE 
ページトップへ